Hematologic Malignancy
Pediatric and/or Germline Mutation-Associated Myeloid Disorders
CI-CAN-00001395Explore in graph →
PediatricHematologicNon-malignant16 active trials1 approved drugs1 evidence items
- NCIt
- C198663
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001395Explore in graph →
Clinical trials
63 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00852709 | Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias(POE07-01) | terminated | Phase 1 | 35 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 2 | Feb 15, 2018 | clinicaltrials |
| NCT00669890 | Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML(High Risk) | terminated | Phase 1 | 12 | New York Medical College |
| 1 |
| Apr 22, 2015 |
| clinicaltrials |
Data updated 22 days agoSource updated Feb 15, 2018source: clinicaltrials